Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 323 entries
Sorted by: Best Match Show Resources per page
Evaluation of patients' satisfaction with anesthesia in gastrointestinal endoscopic procedures in Iran.

Gastroenterology and hepatology from bed to bench

Iravani S, Frootan M, Zojaji H, Azizi M, Saeedi S, Hashemi MR, Azimzadeh P.
PMID: 24834185
Gastroenterol Hepatol Bed Bench. 2011;4(4):214-8.

AIM: The purpose of this study was to assess satisfaction level and related factors among patients who had an anesthesia during endoscopic procedures; and also validate a questionnaire for evaluating satisfaction with anesthesia.BACKGROUND: The level of patient satisfaction with...

Cite
Iravani S, Frootan M, Zojaji H, et al. Evaluation of patients' satisfaction with anesthesia in gastrointestinal endoscopic procedures in Iran. Gastroenterol Hepatol Bed Bench. 2011;4(4):214-8
Iravani, S., Frootan, M., Zojaji, H., Azizi, M., Saeedi, S., Hashemi, M. R., & Azimzadeh, P. (2011). Evaluation of patients' satisfaction with anesthesia in gastrointestinal endoscopic procedures in Iran. Gastroenterology and hepatology from bed to bench, 4(4), 214-8.
Iravani, Shahrokh, et al. "Evaluation of patients' satisfaction with anesthesia in gastrointestinal endoscopic procedures in Iran." Gastroenterology and hepatology from bed to bench vol. 4,4 (2011): 214-8.
Iravani S, Frootan M, Zojaji H, Azizi M, Saeedi S, Hashemi MR, Azimzadeh P. Evaluation of patients' satisfaction with anesthesia in gastrointestinal endoscopic procedures in Iran. Gastroenterol Hepatol Bed Bench. 2011;4(4):214-8. PMID: 24834185; PMCID: PMC4017439.
Copy Download .nbib Format: NLM
Zinc, nickel, and cobalt ions removal from aqueous solution and plating plant wastewater by modified .

Data in brief

Foroutan R, Esmaeili H, Rishehri SD, Sadeghzadeh F, Mirahmadi S, Kosarifard M, Ramavandi B.
PMID: 28516145
Data Brief. 2017 May 01;12:485-492. doi: 10.1016/j.dib.2017.04.031. eCollection 2017 Jun.

The biomass of

Cite
Foroutan R, Esmaeili H, Rishehri SD, et al. Zinc, nickel, and cobalt ions removal from aqueous solution and plating plant wastewater by modified . Data Brief. 2017;12:485-492doi: 10.1016/j.dib.2017.04.031.
Foroutan, R., Esmaeili, H., Rishehri, S. D., Sadeghzadeh, F., Mirahmadi, S., Kosarifard, M., & Ramavandi, B. (2017). Zinc, nickel, and cobalt ions removal from aqueous solution and plating plant wastewater by modified . Data in brief, 12485-492. https://doi.org/10.1016/j.dib.2017.04.031
Foroutan, Rauf, et al. "Zinc, nickel, and cobalt ions removal from aqueous solution and plating plant wastewater by modified ." Data in brief vol. 12 (2017): 485-492. doi: https://doi.org/10.1016/j.dib.2017.04.031
Foroutan R, Esmaeili H, Rishehri SD, Sadeghzadeh F, Mirahmadi S, Kosarifard M, Ramavandi B. Zinc, nickel, and cobalt ions removal from aqueous solution and plating plant wastewater by modified . Data Brief. 2017 May 01;12:485-492. doi: 10.1016/j.dib.2017.04.031. eCollection 2017 Jun. PMID: 28516145; PMCID: PMC5425339.
Copy Download .nbib Format: NLM
A local quality initiative to improve follow-up times for patients with heart failure.

BMJ open quality

Schofield T, Duero Posada J, Foroutan F, Alba AC, McDonald M, Linghorne M.
PMID: 29450270
BMJ Open Qual. 2017 Sep 24;6(2):e000052. doi: 10.1136/bmjoq-2017-000052. eCollection 2017.

No abstract available.

Cite
Schofield T, Duero Posada J, Foroutan F, et al. A local quality initiative to improve follow-up times for patients with heart failure. BMJ Open Qual. 2017;6(2):e000052doi: 10.1136/bmjoq-2017-000052.
Schofield, T., Duero Posada, J., Foroutan, F., Alba, A. C., McDonald, M., & Linghorne, M. (2017). A local quality initiative to improve follow-up times for patients with heart failure. BMJ open quality, 6(2), e000052. https://doi.org/10.1136/bmjoq-2017-000052
Schofield, Toni, et al. "A local quality initiative to improve follow-up times for patients with heart failure." BMJ open quality vol. 6,2 (2017): e000052. doi: https://doi.org/10.1136/bmjoq-2017-000052
Schofield T, Duero Posada J, Foroutan F, Alba AC, McDonald M, Linghorne M. A local quality initiative to improve follow-up times for patients with heart failure. BMJ Open Qual. 2017 Sep 24;6(2):e000052. doi: 10.1136/bmjoq-2017-000052. eCollection 2017. PMID: 29450270; PMCID: PMC5699116.
Copy Download .nbib Format: NLM
The efficacy of nebulized furosemide and salbutamol compared with salbutamol alone in reactive airway disease: a double blind randomized, clinical trial.

Emergency medicine international

Masoumi K, Forouzan A, Haddadzadeh Shoushtari M, Porozan S, Feli M, Fallah Bagher Sheidaee M, Asgari Darian A.
PMID: 24876968
Emerg Med Int. 2014;2014:638102. doi: 10.1155/2014/638102. Epub 2014 Apr 27.

We undertook this randomized clinical trial to investigate whether adding furosemide to salbutamol could improve the peak expiratory flow rate (PEFR) and clinical signs of reactive airway disease (RAD) patients. Eligible 18- to 55-year-old patients were randomly divided into...

Cite
Masoumi K, Forouzan A, Haddadzadeh Shoushtari M, et al. The efficacy of nebulized furosemide and salbutamol compared with salbutamol alone in reactive airway disease: a double blind randomized, clinical trial. Emerg Med Int. 2014;2014:638102doi: 10.1155/2014/638102.
Masoumi, K., Forouzan, A., Haddadzadeh Shoushtari, M., Porozan, S., Feli, M., Fallah Bagher Sheidaee, M., & Asgari Darian, A. (2014). The efficacy of nebulized furosemide and salbutamol compared with salbutamol alone in reactive airway disease: a double blind randomized, clinical trial. Emergency medicine international, 2014638102. https://doi.org/10.1155/2014/638102
Masoumi, Kambiz, et al. "The efficacy of nebulized furosemide and salbutamol compared with salbutamol alone in reactive airway disease: a double blind randomized, clinical trial." Emergency medicine international vol. 2014 (2014): 638102. doi: https://doi.org/10.1155/2014/638102
Masoumi K, Forouzan A, Haddadzadeh Shoushtari M, Porozan S, Feli M, Fallah Bagher Sheidaee M, Asgari Darian A. The efficacy of nebulized furosemide and salbutamol compared with salbutamol alone in reactive airway disease: a double blind randomized, clinical trial. Emerg Med Int. 2014;2014:638102. doi: 10.1155/2014/638102. Epub 2014 Apr 27. PMID: 24876968; PMCID: PMC4020390.
Copy Download .nbib Format: NLM
Gallstone disease founded by ultrasonography in functional dyspepsia: prevalence and associated factors.

International journal of clinical and experimental medicine

Froutan Y, Alizadeh A, Mansour-Ghanaei F, Joukar F, Froutan H, Bagheri FB, Naghipour MR, Chavoshi SA.
PMID: 26379936
Int J Clin Exp Med. 2015 Jul 15;8(7):11283-8. eCollection 2015.

The aim of this study was to evaluate the frequency of gallbladder stone in functional dyspepsia (FD) by abdominal ultrasonography and to determine the factors associated with this frequency in Guilan province. A total of 195 subjects who referred...

Cite
Froutan Y, Alizadeh A, Mansour-Ghanaei F, et al. Gallstone disease founded by ultrasonography in functional dyspepsia: prevalence and associated factors. Int J Clin Exp Med. 2015;8(7):11283-8
Froutan, Y., Alizadeh, A., Mansour-Ghanaei, F., Joukar, F., Froutan, H., Bagheri, F. B., Naghipour, M. R., & Chavoshi, S. A. (2015). Gallstone disease founded by ultrasonography in functional dyspepsia: prevalence and associated factors. International journal of clinical and experimental medicine, 8(7), 11283-8.
Froutan, Yaser, et al. "Gallstone disease founded by ultrasonography in functional dyspepsia: prevalence and associated factors." International journal of clinical and experimental medicine vol. 8,7 (2015): 11283-8.
Froutan Y, Alizadeh A, Mansour-Ghanaei F, Joukar F, Froutan H, Bagheri FB, Naghipour MR, Chavoshi SA. Gallstone disease founded by ultrasonography in functional dyspepsia: prevalence and associated factors. Int J Clin Exp Med. 2015 Jul 15;8(7):11283-8. eCollection 2015. PMID: 26379936; PMCID: PMC4565319.
Copy Download .nbib Format: NLM
Transcatheter or surgical aortic valve replacement for patients with severe, symptomatic, aortic stenosis at low to intermediate surgical risk: a clinical practice guideline.

BMJ (Clinical research ed.)

Vandvik PO, Otto CM, Siemieniuk RA, Bagur R, Guyatt GH, Lytvyn L, Whitlock R, Vartdal T, Brieger D, Aertgeerts B, Price S, Foroutan F, Shapiro M, Mertz R, Spencer FA.
PMID: 27680583
BMJ. 2016 Sep 28;354:i5085. doi: 10.1136/bmj.i5085.

No abstract available.

Cite
Vandvik PO, Otto CM, Siemieniuk RA, et al. Transcatheter or surgical aortic valve replacement for patients with severe, symptomatic, aortic stenosis at low to intermediate surgical risk: a clinical practice guideline. BMJ. 2016;354:i5085doi: 10.1136/bmj.i5085.
Vandvik, P. O., Otto, C. M., Siemieniuk, R. A., Bagur, R., Guyatt, G. H., Lytvyn, L., Whitlock, R., Vartdal, T., Brieger, D., Aertgeerts, B., Price, S., Foroutan, F., Shapiro, M., Mertz, R., & Spencer, F. A. (2016). Transcatheter or surgical aortic valve replacement for patients with severe, symptomatic, aortic stenosis at low to intermediate surgical risk: a clinical practice guideline. BMJ (Clinical research ed.), 354i5085. https://doi.org/10.1136/bmj.i5085
Vandvik, Per O, et al. "Transcatheter or surgical aortic valve replacement for patients with severe, symptomatic, aortic stenosis at low to intermediate surgical risk: a clinical practice guideline." BMJ (Clinical research ed.) vol. 354 (2016): i5085. doi: https://doi.org/10.1136/bmj.i5085
Vandvik PO, Otto CM, Siemieniuk RA, Bagur R, Guyatt GH, Lytvyn L, Whitlock R, Vartdal T, Brieger D, Aertgeerts B, Price S, Foroutan F, Shapiro M, Mertz R, Spencer FA. Transcatheter or surgical aortic valve replacement for patients with severe, symptomatic, aortic stenosis at low to intermediate surgical risk: a clinical practice guideline. BMJ. 2016 Sep 28;354:i5085. doi: 10.1136/bmj.i5085. PMID: 27680583.
Copy Download .nbib Format: NLM
Six-month follow-up study of ultrarapid opiate detoxification with naltrexone.

International journal of high risk behaviors & addiction

Forozeshfard M, Hosseinzadeh Zoroufchi B, Saberi Zafarghandi MB, Bandari R, Foroutan B.
PMID: 25741479
Int J High Risk Behav Addict. 2014 Sep 17;3(4):e20944. doi: 10.5812/ijhrba.20944. eCollection 2014 Dec.

BACKGROUND: Illicit opiate use has an increasing incidence and prevalence, which increases mortality and morbidity, marginalization, and criminal behaviors, and causes major adverse effects on society.OBJECTIVES: This study aimed to investigate and follow the outcome of patients who underwent...

Cite
Forozeshfard M, Hosseinzadeh Zoroufchi B, Saberi Zafarghandi MB, et al. Six-month follow-up study of ultrarapid opiate detoxification with naltrexone. Int J High Risk Behav Addict. 2014;3(4):e20944doi: 10.5812/ijhrba.20944.
Forozeshfard, M., Hosseinzadeh Zoroufchi, B., Saberi Zafarghandi, M. B., Bandari, R., & Foroutan, B. (2014). Six-month follow-up study of ultrarapid opiate detoxification with naltrexone. International journal of high risk behaviors & addiction, 3(4), e20944. https://doi.org/10.5812/ijhrba.20944
Forozeshfard, Mohammad, et al. "Six-month follow-up study of ultrarapid opiate detoxification with naltrexone." International journal of high risk behaviors & addiction vol. 3,4 (2014): e20944. doi: https://doi.org/10.5812/ijhrba.20944
Forozeshfard M, Hosseinzadeh Zoroufchi B, Saberi Zafarghandi MB, Bandari R, Foroutan B. Six-month follow-up study of ultrarapid opiate detoxification with naltrexone. Int J High Risk Behav Addict. 2014 Sep 17;3(4):e20944. doi: 10.5812/ijhrba.20944. eCollection 2014 Dec. PMID: 25741479; PMCID: PMC4331657.
Copy Download .nbib Format: NLM
Findings of impedance pH-monitoring in patients with atypical gastroesophageal reflux symptoms.

Gastroenterology and hepatology from bed to bench

Forootan M, Ardeshiri M, Etemadi N, Maghsoodi N, Poorsaadati S.
PMID: 24834281
Gastroenterol Hepatol Bed Bench. 2013;6:S117-21.

AIM: This study was designed to investigate about findings of Impedance pH-monitoring in patients with atypical symptoms of GERD.BACKGROUND: The routine treatment with proton pump inhibitors is not very effective in patients with atypical symptoms of Gastro-Esophageal Reflux Disease...

Cite
Forootan M, Ardeshiri M, Etemadi N, et al. Findings of impedance pH-monitoring in patients with atypical gastroesophageal reflux symptoms. Gastroenterol Hepatol Bed Bench. 2013;6:S117-21
Forootan, M., Ardeshiri, M., Etemadi, N., Maghsoodi, N., & Poorsaadati, S. (2013). Findings of impedance pH-monitoring in patients with atypical gastroesophageal reflux symptoms. Gastroenterology and hepatology from bed to bench, 6S117-21.
Forootan, Mojgan, et al. "Findings of impedance pH-monitoring in patients with atypical gastroesophageal reflux symptoms." Gastroenterology and hepatology from bed to bench vol. 6 (2013): S117-21.
Forootan M, Ardeshiri M, Etemadi N, Maghsoodi N, Poorsaadati S. Findings of impedance pH-monitoring in patients with atypical gastroesophageal reflux symptoms. Gastroenterol Hepatol Bed Bench. 2013;6:S117-21. PMID: 24834281; PMCID: PMC4017544.
Copy Download .nbib Format: NLM
Budget impact analysis of conversion from cyclosporine to sirolimus as immunosuppressive medication in renal transplantation therapy.

ClinicoEconomics and outcomes research : CEOR

Foroutan N, Rasekh HR, Salamzadeh J, Jamshidi HR, Nafar M.
PMID: 24159260
Clinicoecon Outcomes Res. 2013 Oct 18;5:545-53. doi: 10.2147/CEOR.S51446. eCollection 2013.

OBJECTIVES: The aim of this study was to determine budget impact of conversion from cyclosporine (CsA) to sirolimus (SRL) in renal transplant therapy (RTT) from the perspective of insurance organizations in Iran.METHODS: An Excel-based model was developed to determine...

Cite
Foroutan N, Rasekh HR, Salamzadeh J, et al. Budget impact analysis of conversion from cyclosporine to sirolimus as immunosuppressive medication in renal transplantation therapy. Clinicoecon Outcomes Res. 2013;5:545-53doi: 10.2147/CEOR.S51446.
Foroutan, N., Rasekh, H. R., Salamzadeh, J., Jamshidi, H. R., & Nafar, M. (2013). Budget impact analysis of conversion from cyclosporine to sirolimus as immunosuppressive medication in renal transplantation therapy. ClinicoEconomics and outcomes research : CEOR, 5545-53. https://doi.org/10.2147/CEOR.S51446
Foroutan, Naghmeh, et al. "Budget impact analysis of conversion from cyclosporine to sirolimus as immunosuppressive medication in renal transplantation therapy." ClinicoEconomics and outcomes research : CEOR vol. 5 (2013): 545-53. doi: https://doi.org/10.2147/CEOR.S51446
Foroutan N, Rasekh HR, Salamzadeh J, Jamshidi HR, Nafar M. Budget impact analysis of conversion from cyclosporine to sirolimus as immunosuppressive medication in renal transplantation therapy. Clinicoecon Outcomes Res. 2013 Oct 18;5:545-53. doi: 10.2147/CEOR.S51446. eCollection 2013. PMID: 24159260; PMCID: PMC3806112.
Copy Download .nbib Format: NLM
Development and Validation of an HPLC Method for Determination of Amifostine and/or Its Metabolite (WR-1065) In Human Plasma Using OPA Derivatization and UV Detection.

Iranian journal of pharmaceutical research : IJPR

Samiei N, Foroutan SM, Shafaati A, Zarghi A.
PMID: 26664371
Iran J Pharm Res. 2015;14(4):1051-7.

A rapid, sensitive and reproducible HPLC method was developed and validated for the analysis of amifostine (AMF) and/or its metabolite, WR-1065 in human plasma. The method involves the alkylation of free sulfydryl group with iodoacetic acid followed by derivatization...

Cite
Samiei N, Foroutan SM, Shafaati A, et al. Development and Validation of an HPLC Method for Determination of Amifostine and/or Its Metabolite (WR-1065) In Human Plasma Using OPA Derivatization and UV Detection. Iran J Pharm Res. 2015;14(4):1051-7
Samiei, N., Foroutan, S. M., Shafaati, A., & Zarghi, A. (2015). Development and Validation of an HPLC Method for Determination of Amifostine and/or Its Metabolite (WR-1065) In Human Plasma Using OPA Derivatization and UV Detection. Iranian journal of pharmaceutical research : IJPR, 14(4), 1051-7.
Samiei, Nasim, et al. "Development and Validation of an HPLC Method for Determination of Amifostine and/or Its Metabolite (WR-1065) In Human Plasma Using OPA Derivatization and UV Detection." Iranian journal of pharmaceutical research : IJPR vol. 14,4 (2015): 1051-7.
Samiei N, Foroutan SM, Shafaati A, Zarghi A. Development and Validation of an HPLC Method for Determination of Amifostine and/or Its Metabolite (WR-1065) In Human Plasma Using OPA Derivatization and UV Detection. Iran J Pharm Res. 2015;14(4):1051-7. PMID: 26664371; PMCID: PMC4673932.
Copy Download .nbib Format: NLM
Stereolithography: application to neurosurgery.

Critical reviews in neurosurgery : CR

Foroutan M, Fallahi B, Mottavalli S, Dujovny M.
PMID: 9683679
Crit Rev Neurosurg. 1998 Jul 20;8(4):203-8. doi: 10.1007/s003290050078.

Computer-aided design (CAD) and computer-aided manufacturing (CAM) by stereolithography are already being widely used in industry for the design and manufacture of new parts and have already shown accuracy in reproducing the desired model. The only shortcoming of this...

Cite
Foroutan M, Fallahi B, Mottavalli S, et al. Stereolithography: application to neurosurgery. Crit Rev Neurosurg. 1998;8(4):203-8doi: 10.1007/s003290050078.
Foroutan, M., Fallahi, B., Mottavalli, S., & Dujovny, M. (1998). Stereolithography: application to neurosurgery. Critical reviews in neurosurgery : CR, 8(4), 203-8. https://doi.org/10.1007/s003290050078
Foroutan, et al. "Stereolithography: application to neurosurgery." Critical reviews in neurosurgery : CR vol. 8,4 (1998): 203-8. doi: https://doi.org/10.1007/s003290050078
Foroutan M, Fallahi B, Mottavalli S, Dujovny M. Stereolithography: application to neurosurgery. Crit Rev Neurosurg. 1998 Jul 20;8(4):203-8. doi: 10.1007/s003290050078. PMID: 9683679.
Copy Download .nbib Format: NLM
Botulinium toxin, as bridge to transanal pullthrough in neonate with Hirschsprungs disease.

Journal of Indian Association of Pediatric Surgeons

Hosseini SM, Foroutan HR, Zeraatian S, Sabet B.
PMID: 20011471
J Indian Assoc Pediatr Surg. 2008 Apr;13(2):69-71. doi: 10.4103/0971-9261.43025.

AIMS AND OBJECTIVES: The aim of this study is to find easier way of home care while obviating the colostomy before single stage pull through operation.MATERIALS AND METHODS: From August 2005 to December 2006, eight cases of neonatal Hirschsprung...

Cite
Hosseini SM, Foroutan HR, Zeraatian S, et al. Botulinium toxin, as bridge to transanal pullthrough in neonate with Hirschsprungs disease. J Indian Assoc Pediatr Surg. 2008;13(2):69-71doi: 10.4103/0971-9261.43025.
Hosseini, S. M., Foroutan, H. R., Zeraatian, S., & Sabet, B. (2008). Botulinium toxin, as bridge to transanal pullthrough in neonate with Hirschsprungs disease. Journal of Indian Association of Pediatric Surgeons, 13(2), 69-71. https://doi.org/10.4103/0971-9261.43025
Hosseini, S M V, et al. "Botulinium toxin, as bridge to transanal pullthrough in neonate with Hirschsprungs disease." Journal of Indian Association of Pediatric Surgeons vol. 13,2 (2008): 69-71. doi: https://doi.org/10.4103/0971-9261.43025
Hosseini SM, Foroutan HR, Zeraatian S, Sabet B. Botulinium toxin, as bridge to transanal pullthrough in neonate with Hirschsprungs disease. J Indian Assoc Pediatr Surg. 2008 Apr;13(2):69-71. doi: 10.4103/0971-9261.43025. PMID: 20011471; PMCID: PMC2788448.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 323 entries